101 related articles for article (PubMed ID: 18649951)
1. Mutant amyloid-beta-sensitized dendritic cells as Alzheimer's disease vaccine.
Cao C; Lin X; Zhang C; Wahi MM; Wefes I; Arendash G; Potter H
J Neuroimmunol; 2008 Aug; 200(1-2):1-10. PubMed ID: 18649951
[TBL] [Abstract][Full Text] [Related]
2. Virus and virus-like particle-based immunogens for Alzheimer's disease induce antibody responses against amyloid-beta without concomitant T cell responses.
Chackerian B; Rangel M; Hunter Z; Peabody DS
Vaccine; 2006 Sep; 24(37-39):6321-31. PubMed ID: 16806604
[TBL] [Abstract][Full Text] [Related]
3. Vaccination of Alzheimer's model mice with adenovirus vector containing quadrivalent foldable Abeta(1-15) reduces Abeta burden and behavioral impairment without Abeta-specific T cell response.
Zou J; Yao Z; Zhang G; Wang H; Xu J; Yew DT; Forster EL
J Neurol Sci; 2008 Sep; 272(1-2):87-98. PubMed ID: 18571202
[TBL] [Abstract][Full Text] [Related]
4. Liposomal vaccines with conformation-specific amyloid peptide antigens define immune response and efficacy in APP transgenic mice.
Muhs A; Hickman DT; Pihlgren M; Chuard N; Giriens V; Meerschman C; van der Auwera I; van Leuven F; Sugawara M; Weingertner MC; Bechinger B; Greferath R; Kolonko N; Nagel-Steger L; Riesner D; Brady RO; Pfeifer A; Nicolau C
Proc Natl Acad Sci U S A; 2007 Jun; 104(23):9810-5. PubMed ID: 17517595
[TBL] [Abstract][Full Text] [Related]
5. Dendrimeric Abeta1-15 is an effective immunogen in wildtype and APP-tg mice.
Seabrook TJ; Thomas K; Jiang L; Bloom J; Spooner E; Maier M; Bitan G; Lemere CA
Neurobiol Aging; 2007 Jun; 28(6):813-23. PubMed ID: 16725229
[TBL] [Abstract][Full Text] [Related]
6. Immunogenic, antigenic, fibrillogenic and inflammatory properties of new simplified beta-amyloid peptides.
Rossi M; Piovesan P; Ghirardi O; Mastroianni D; Bombardi V; Battistini L; Cencioni MT; Capobianco D; Borsini F; Colombo M; Verdoliva A
Mol Immunol; 2009 Aug; 46(13):2524-32. PubMed ID: 19535144
[TBL] [Abstract][Full Text] [Related]
7. Induction of anti-inflammatory immune response by an adenovirus vector encoding 11 tandem repeats of Abeta1-6: toward safer and effective vaccines against Alzheimer's disease.
Kim HD; Maxwell JA; Kong FK; Tang DC; Fukuchi K
Biochem Biophys Res Commun; 2005 Oct; 336(1):84-92. PubMed ID: 16126169
[TBL] [Abstract][Full Text] [Related]
8. Specific humoral immune responses in rhesus monkeys vaccinated with the Alzheimer's disease-associated beta-amyloid 1-15 peptide vaccine.
Li SB; Wang HQ; Lin X; Xu J; Xie Y; Yuan QF; Yao ZB
Chin Med J (Engl); 2005 Apr; 118(8):660-4. PubMed ID: 15899121
[TBL] [Abstract][Full Text] [Related]
9. Site-specific UBITh amyloid-beta vaccine for immunotherapy of Alzheimer's disease.
Wang CY; Finstad CL; Walfield AM; Sia C; Sokoll KK; Chang TY; Fang XD; Hung CH; Hutter-Paier B; Windisch M
Vaccine; 2007 Apr; 25(16):3041-52. PubMed ID: 17287052
[TBL] [Abstract][Full Text] [Related]
10. Differences in the immune response to long term Abeta vaccination in C57BL/6 and B6D2F1 mice.
Seabrook TJ; Iglesias M; Bloom JK; Spooner ET; Lemere CA
Vaccine; 2004 Sep; 22(29-30):4075-83. PubMed ID: 15364459
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR alleles in amyloid beta-peptide autoimmunity: a highly immunogenic role for the DRB1*1501 allele.
Zota V; Nemirovsky A; Baron R; Fisher Y; Selkoe DJ; Altmann DM; Weiner HL; Monsonego A
J Immunol; 2009 Sep; 183(5):3522-30. PubMed ID: 19675171
[TBL] [Abstract][Full Text] [Related]
12. Absence of effect of chronic nicotine administration on amyloid beta peptide levels in transgenic mice overexpressing mutated human APP (Sw, Ind).
Sabbagh MN; Walker DG; Reid RT; Stadnick T; Anand K; Lue LF
Neurosci Lett; 2008 Dec; 448(2):217-20. PubMed ID: 18926877
[TBL] [Abstract][Full Text] [Related]
13. Direct in vivo intracellular selection of conformation-sensitive antibody domains targeting Alzheimer's amyloid-beta oligomers.
Meli G; Visintin M; Cannistraci I; Cattaneo A
J Mol Biol; 2009 Apr; 387(3):584-606. PubMed ID: 19361429
[TBL] [Abstract][Full Text] [Related]
14. Amyloid beta peptides with an additional cysteine residue can enhance immunogenicity and reduce the amyloid beta burden in an Alzheimer's disease mouse model.
Matsuda J; Kaminaka K; Nozaki C
Biochem Biophys Res Commun; 2009 Apr; 382(1):149-52. PubMed ID: 19265678
[TBL] [Abstract][Full Text] [Related]
15. Sphingomyelinase dependent apoptosis of dendritic cells following treatment with amyloid peptides.
Xuan NT; Shumilina E; Kempe DS; Gulbins E; Lang F
J Neuroimmunol; 2010 Feb; 219(1-2):81-9. PubMed ID: 20060598
[TBL] [Abstract][Full Text] [Related]
16. Mapping of immune responses following wild-type and mutant ABeta42 plasmid or peptide vaccination in different mouse haplotypes and HLA Class II transgenic mice.
Kutzler MA; Cao C; Bai Y; Dong H; Choe PY; Saulino V; McLaughlin L; Whelan A; Choo AY; Weiner DB; Ugen KE
Vaccine; 2006 May; 24(21):4630-9. PubMed ID: 16157426
[TBL] [Abstract][Full Text] [Related]
17. Reduced oligomeric and vascular amyloid-beta following immunization of TgCRND8 mice with an Alzheimer's DNA vaccine.
DaSilva KA; Brown ME; McLaurin J
Vaccine; 2009 Feb; 27(9):1365-76. PubMed ID: 19150380
[TBL] [Abstract][Full Text] [Related]
18. A novel monoclonal antibody specific for the amino-truncated beta-amyloid Abeta5-40/42 produced from caspase-cleaved amyloid precursor protein.
Murayama KS; Kametani F; Tabira T; Araki W
J Neurosci Methods; 2007 Apr; 161(2):244-9. PubMed ID: 17207535
[TBL] [Abstract][Full Text] [Related]
19. Sensitive ELISA detection of amyloid-beta protofibrils in biological samples.
Englund H; Sehlin D; Johansson AS; Nilsson LN; Gellerfors P; Paulie S; Lannfelt L; Pettersson FE
J Neurochem; 2007 Oct; 103(1):334-45. PubMed ID: 17623042
[TBL] [Abstract][Full Text] [Related]
20. Polypeptide conjugates comprising a beta-amyloid plaque-specific epitope as new vaccine structures against Alzheimer's disease.
Manea M; Mezö G; Hudecz F; Przybylski M
Biopolymers; 2004; 76(6):503-11. PubMed ID: 15499564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
